2 matches for your search in the start-up spotlight
rss
matching the following criteria
Sort by:
Hedera Dx
Founded in Switzerland in 2021 by Tommi Lehtonen, Damien Lapray and Christian Meisel, Hedera Dx is on a mission to make liquid biopsies a reality in clinical practice globally, in order to help more cancer patients get better therapy options and better outcomes. The Hedera Dx liquid biopsy ...
Parithera SA
Parithera enables accurate treatment decision guidance & monitoring from one simple blood draw An alternative to tissue biopsy is to study cells which detach from the solid tumors and find access to the blood stream. The so-called circulating tumor cells (CTCs) are retrieved via Liquid ...
